Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe
about
Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents.Costs of care for lung and colon cancer patients receiving chemotherapy following FDA policy changes.APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania.
P2860
Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@ast
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@en
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@nl
type
label
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@ast
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@en
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@nl
prefLabel
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@ast
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@en
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@nl
P2093
P2860
P921
P1476
Hemoglobin level at initiation ...... ced anemia treatment in Europe
@en
P2093
Lucie Kutikova
Melike Deger
Wolfgang Eisterer
P2860
P2888
P304
P356
10.1007/S00520-012-1538-0
P407
P577
2013-02-01T00:00:00Z
P5875
P6179
1009622664